HIGGINS JOHN L — SEC insider filings

SEC reporting owner CIK 1208906. 59 insider filings on record with FilingPulse; latest filed 2026-11-02.

Transaction summary — filings shown

Covers the 50 most recent of 59 filings on record, filed 2021-07-02 to 2026-11-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
LIGAND PHARMACEUTICALS INC (LGND)Director18—6 legs · 29,000 sh · $2,419,44023
BIO-TECHNE Corp (TECH)Director15—8 legs · 8,104 sh · $1,867,85734
OmniAb, Inc. (OABI)Director175 legs · 272,011 sh · $505,9393 legs · 60,000 sh · $235,00044

Insider filings — HIGGINS JOHN L

FiledFormIssuerReported transactionsSource
2026-11-024BIO-TECHNE Corp (TECH)Grant/award (A): 2,750 @ $0EDGAR
2026-09-304BIO-TECHNE Corp (TECH)Option exercise (M): 15,940 @ $0 · Tax withholding (F): 5,562 @ $72.51 · Option exercise (M): 15,940 (derivative) @ $0EDGAR
2026-06-184OmniAb, Inc. (OABI)Option exercise (M): 20,000 · Option exercise (M): 20,000 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0EDGAR
2026-01-304OmniAb, Inc. (OABI)Option exercise (M): 13,172 · Option exercise (M): 13,172 (derivative) @ $0EDGAR
2025-11-104OmniAb, Inc. (OABI)Purchase (P): 36,223 @ $1.41 · Purchase (P): 41,038 @ $1.38EDGAR
2025-11-034BIO-TECHNE Corp (TECH)Grant/award (A): 1,640 @ $0 · Grant/award (A): 3,777 (derivative) @ $0EDGAR
2025-08-114BIO-TECHNE Corp (TECH)Option exercise (M): 5,040 @ $21.84 · Option exercise (M): 5,040 (derivative) @ $0EDGAR
2025-06-184OmniAb, Inc. (OABI)Option exercise (M): 20,000 · Option exercise (M): 20,000 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0EDGAR
2025-05-134OmniAb, Inc. (OABI)Purchase (P): 65,000 @ $1.44EDGAR
2025-05-054BIO-TECHNE Corp (TECH)Option exercise (M): 12,000 @ $21.84 · Option exercise (M): 12,000 (derivative) @ $0EDGAR
2025-03-214OmniAb, Inc. (OABI)Purchase (P): 4,000 @ $2.28EDGAR
2025-03-204OmniAb, Inc. (OABI)Purchase (P): 125,750 @ $2.35EDGAR
2025-01-304OmniAb, Inc. (OABI)Option exercise (M): 13,172 · Option exercise (M): 13,172 (derivative) @ $0EDGAR
2024-10-284BIO-TECHNE Corp (TECH)Grant/award (A): 1,462 @ $0 · Grant/award (A): 3,511 (derivative) @ $0EDGAR
2024-09-164BIO-TECHNE Corp (TECH)Option exercise (M): 6,000 @ $22.95 · Tax withholding (F): 1,874 @ $73.20 · Option exercise (M): 6,000 (derivative) @ $0EDGAR
2024-07-104BIO-TECHNE Corp (TECH)Option exercise (M): 6,000 @ $22.95 · Option exercise (M): 6,000 (derivative) @ $0EDGAR
2024-06-214OmniAb, Inc. (OABI)Option exercise (M): 20,000 · Option exercise (M): 20,000 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0EDGAR
2024-05-164BIO-TECHNE Corp (TECH)Option exercise (M): 4,000 @ $22.95 · Sale (S): 4,000 @ $83.84 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2024-04-234/AOmniAb, Inc. (OABI)Grant/award (A): 2,427,861EDGAR
2024-01-314OmniAb, Inc. (OABI)Option exercise (M): 13,173 · Option exercise (M): 13,173 (derivative) @ $0EDGAR
2023-10-304BIO-TECHNE Corp (TECH)Grant/award (A): 1,625 @ $0 · Grant/award (A): 3,937 (derivative) @ $0EDGAR
2023-06-274OmniAb, Inc. (OABI)Tax withholding (F): 25,914 @ $3.66 · Tax withholding (F): 57,803 @ $3.23 · Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0EDGAR
2023-05-254OmniAb, Inc. (OABI)Option exercise (M): 9,000 @ $3.68 · Sale (S): 9,000 @ $4.05 · Option exercise (M): 9,000 (derivative) @ $0EDGAR
2023-05-234OmniAb, Inc. (OABI)Option exercise (M): 1,000 @ $3.68 · Sale (S): 1,000 @ $4.05 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2023-05-194OmniAb, Inc. (OABI)Option exercise (M): 50,000 @ $3.68 · Sale (S): 50,000 @ $3.89 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2023-05-024BIO-TECHNE Corp (TECH)Option exercise (M): 16,000 @ $21.85 · Tax withholding (F): 4,377 @ $79.88 · Option exercise (M): 16,000 (derivative) @ $0EDGAR
2023-02-014OmniAb, Inc. (OABI)Grant/award (A): 39,517 @ $0 · Grant/award (A): 142,020 (derivative) @ $0EDGAR
2022-12-304LIGAND PHARMACEUTICALS INC (LGND)Tax withholding (F): 5,289 @ $66.29EDGAR
2022-12-274LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 92,932 (derivative) @ $0EDGAR
2022-12-204LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 10,000 @ $61.87EDGAR
2022-12-144LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 20,000 @ $12.78 · Disposition to issuer (D): 3,944 @ $64.80 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2022-12-014LIGAND PHARMACEUTICALS INC (LGND)Tax withholding (F): 9,803 @ $72.90EDGAR
2022-11-214LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 10,000 @ $78.32 · Option exercise (M): 10,000 @ $12.78 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2022-11-074/ALIGAND PHARMACEUTICALS INC (LGND)Holdings only — no transactions reportedEDGAR
2022-11-034LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 45,922 @ $0EDGAR
2022-11-034OmniAb, Inc. (OABI)Grant/award (A): 2,176,521 · Option exercise (M): 246,648 @ $2.52 · Grant/award (A): 246,648 (derivative) · Grant/award (A): 61,362 (derivative) · Grant/award (A): 400,808 (derivative) · Grant/award (A): 232,971 (derivative) · +7 moreEDGAR
2022-10-314BIO-TECHNE Corp (TECH)Grant/award (A): 338 @ $0 · Grant/award (A): 865 (derivative) @ $0EDGAR
2022-09-224/ALIGAND PHARMACEUTICALS INC (LGND)Sale (S): 1,000 @ $88.06EDGAR
2022-09-164LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 2,000 @ $90 · Sale (S): 3,000 @ $89.35EDGAR
2022-08-124BIO-TECHNE Corp (TECH)Option exercise (M): 3,400 @ $66.90 · Sale (S): 900 @ $373.99 · Sale (S): 100 @ $374.89 · Sale (S): 992 @ $380.15 · Sale (S): 504 @ $385.47 · Sale (S): 8 @ $380.71 · +1 moreEDGAR
2022-07-064LIGAND PHARMACEUTICALS INC (LGND)Other (J): 164 @ $75.84EDGAR
2022-06-144LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 20,423 @ $0EDGAR
2022-06-094BIO-TECHNE Corp (TECH)Option exercise (M): 1,000 @ $66.90 · Sale (S): 1,000 @ $364.31 · Option exercise (M): 600 @ $66.90 · Sale (S): 600 @ $366.09 · Option exercise (M): 1,000 (derivative) @ $0 · Option exercise (M): 600 (derivative) @ $0EDGAR
2022-05-104LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 8,000 @ $21.92 · Sale (S) @ $429,159.38 · Option exercise (M): 8,000 (derivative) @ $0EDGAR
2022-05-094LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 76,478 (derivative) @ $0EDGAR
2022-02-164LIGAND PHARMACEUTICALS INC (LGND)Tax withholding (F): 1,946 @ $123.68 · Tax withholding (F): 2,061 @ $123.68 · Tax withholding (F): 1,916 @ $123.68EDGAR
2022-01-284LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 9,606 @ $0 · Grant/award (A): 13,560 @ $0 · Tax withholding (F): 3,060 @ $113.68 · Tax withholding (F): 6,183 @ $113.68EDGAR
2021-11-124LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 3,000 @ $160.50EDGAR
2021-11-014BIO-TECHNE Corp (TECH)Grant/award (A): 194 @ $0 · Grant/award (A): 633 (derivative) @ $0EDGAR
2021-07-024LIGAND PHARMACEUTICALS INC (LGND)Other (J): 247 @ $85.91EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1208906 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs